ArticleCancer research communications2023

EphA2 Proteolytic Fragment as a Sensitive Diagnostic Biomarker for Very Early-stage Pancreatic Ductal Carcinoma.

Shinya Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.